Etiometry Platform vs Triomics
Triomics works for a cancer center's trial-screening office. PRISM screens upcoming patients against active trials every night and hands coordinators a cited worklist, and the vendor also offers visit preparation and cancer registry curation. It lists Epic, OncoEMR, iKnowMed and Cerner and says it is approved on the Epic App Marketplace. Memorial Sloan Kettering announced a deployment in November 2025 and disclosed institutional financial interests in Triomics. A PRISM paper appeared in NPJ Digital Medicine in 2024, and the vendor says matching accuracy was about 95%. The PRISM page labels some of its own metrics as placeholders, the vendor makes no FDA claim, and openFDA returns no record for Triomics as applicant or device name. Etiometry is a separate purchase for ICU teams: the vendor says 170-plus studies were enabled by its platform.
Decision support · Reviewed November 2, 2026
Etiometry Platform
by Etiometry · founded 2010
ICU data platform that aggregates monitor and EHR data and runs four FDA-cleared physiologic risk indices.
Triomics
by triomics inc.
Oncology AI agents that match patients to clinical trials, prepare visits and curate cancer registries from notes, reports and faxes.
When to pick each one
Etiometry Platform
- Four FDA-cleared ICU risk indices
- Intended to aid decisions, per the vendor
- Four cleared ICU risk indices, one for adults
Triomics
- Nightly trial screening for cancer centers
- Lists Epic, OncoEMR, iKnowMed and Cerner
- Visit prep and registry curation
Score
Each row shows points earned of points available under the published rubric.
Etiometry Platform
38of 100
Triomics
12of 100
| Dimension | Etiometry Platform | Triomics | Difference |
|---|---|---|---|
| FDA clearance | 12 / 12 | 0 / 12 | +12 |
| HIPAA / SOC2 / BAA | 10 / 10 | 0 / 10 | +10 |
| EHR integrations (count) | 0 / 5.6 | 2.8 / 5.6 | -2.8 |
| Top-3 EHR coverage (Epic / Oracle / Athena) | 0 / 4.8 | 3.4 / 4.8 | -3.4 |
| Bidirectional write-back | 0 / 1.2 | 0 / 1.2 | 0 |
| Peer-reviewed papers | 0 / 21 | 0 / 21 | 0 |
| RCT / meta-analysis / systematic review | 0 / 9 | 0 / 9 | 0 |
| Funding & adoption signal | 3 / 12 | 3 / 12 | 0 |
| Pricing transparency | 1.3 / 2.5 | 1.3 / 2.5 | 0 |
| Years in market | 6 / 6 | 0 / 6 | +6 |
Scroll horizontally to see every column.
Pricing
Etiometry Platform
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | n/a | n/a | No public price. Demo request only. |
Triomics
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | n/a | n/a | No public price. Demo request and synthetic-data sandbox offered. |
Evidence
Etiometry Platform
FDA decisions
K254066 (opens in new tab)510(k)2026-04-03
Etiometry Platform
K241479 (opens in new tab)510(k)2025-02-12
Etiometry Platform (DAV 5.4 RAE 9.2)
K223578 (opens in new tab)510(k)2023-07-07
T3 Platform software
K213423 (opens in new tab)510(k)2023-01-06
T3 Platform software
K213230 (opens in new tab)510(k)2022-06-22
T3 Platform Software
Show 6 more
K202306 (opens in new tab)510(k)2020-11-25
T3 Platform software
K190273 (opens in new tab)510(k)2019-12-08
T3 Platform software
K163065 (opens in new tab)510(k)2017-05-26
T3 Software
K152258 (opens in new tab)510(k)2016-03-31
T3 Software
K151715 (opens in new tab)510(k)2015-10-29
T3 Software
K142732 (opens in new tab)510(k)2015-03-04
T3 Software
Triomics
FDA decisions
No FDA decision cited in our research as of November 2, 2026.
Compliance and integrations
Documented from each vendor’s own pages.
| Spec | Etiometry Platform | Triomics |
|---|---|---|
| Free tier | ||
| HIPAA | ||
| SOC 2 Type II | ||
| EHR integrations | Not specified | Epic, OncoEMR, iKnowMed, Cerner |
| Founded | 2010 | n/a |
| HQ | US | US |
Scroll horizontally to see both columns.
Common questions
Open the full decision support comparison
Differential diagnosis, treatment guidance, drug interactions, evidence-grounded Q&A. The CDS landscape ranges from the UpToDate gold standard to physician-only OpenEvidence. We compared what clinicians actually use.